mortality/aging
• 27% die before reaching 6 months of age and 20% die during echochardiographic or ECG examination
|
• 16% die within the first 2 weeks, the rest reach adulthood
|
cardiovascular system
• adults and 3 month old mice exhibit myofiber hypertrophy
• frequently observe enlarged cardiomyocyte nuclei with abnormal morphology
|
• heart-to-body weight ratios of adults are increased by 26%, indicative of hypertrophy
|
• adults exhibit enlarged ventricular chambers
|
• seen in adults
|
• progressive malfunction of the heart
|
• at 3 months of age, ventricular diameter is increased and fractional shortening is impaired
• hearts do not compensate after aortic banding but display a further decrease in fractional shortening
|
• at 1 month of age, see dilatation and loss of left ventricle contractility
|
• significantly lengthened QTc interval caused by a slowed ventricular repolarization
|
muscle
• adults and 3 month old mice exhibit myofiber hypertrophy
• frequently observe enlarged cardiomyocyte nuclei with abnormal morphology
|
• progressive malfunction of the heart
|
• at 3 months of age, ventricular diameter is increased and fractional shortening is impaired
• hearts do not compensate after aortic banding but display a further decrease in fractional shortening
|
• at 1 month of age, see dilatation and loss of left ventricle contractility
|
growth/size/body
• heart-to-body weight ratios of adults are increased by 26%, indicative of hypertrophy
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
dilated cardiomyopathy | DOID:12930 |
OMIM:PS115200 |
J:77347 |